69 related articles for article (PubMed ID: 6106995)
1. Synthesis and mass spectra of deuterium-labelled ketobemidone and of some potential ketobemidone metabolites.
Bondesson U; Danielsson B; Lindberg C
Acta Pharm Suec; 1980; 17(1):1-11. PubMed ID: 6106995
[No Abstract] [Full Text] [Related]
2. Quantitative determination of the urinary excretion of ketobemidone and four of its metabolites after intravenous and oral administration in man.
Bondesson U; Hartvig P; Danielsson B
Drug Metab Dispos; 1981; 9(4):376-80. PubMed ID: 6114838
[TBL] [Abstract][Full Text] [Related]
3. Single-dose kinetics and bioavailability of ketobemidone.
Anderson P; Arnér S; Bondesson U; Boréus LO; Hartvig P
Acta Anaesthesiol Scand Suppl; 1982; 74():59-62. PubMed ID: 6124079
[TBL] [Abstract][Full Text] [Related]
4. Multiple dose kinetics of ketobemidone in surgical patients.
Bondesson U; Tamsen A; Dahlström B; Hartvig P
Acta Anaesthesiol Scand Suppl; 1982; 74():63-5. PubMed ID: 6124080
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of ketobemidone and its N-demethylated metabolite in patient plasma samples by gas chromatography mass spectrometry with selected ion monitoring.
Bondesson U; Hartvig P; Abrahamsson L; Ahnfelt NO
Biomed Mass Spectrom; 1983 Apr; 10(4):283-6. PubMed ID: 6133568
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics and oral bioavailability of ketobemidone.
Bondesson U; Arnér S; Anderson P; Boréus LO; Hartvig P
Eur J Clin Pharmacol; 1980 Jan; 17(1):45-50. PubMed ID: 6102913
[TBL] [Abstract][Full Text] [Related]
7. Biological fate of pethidine. Applications of gas chromatography-mass spectrometry and deuterium labelling.
Lindberg C
Acta Pharm Suec; 1978; 15(5):400. PubMed ID: 747100
[No Abstract] [Full Text] [Related]
8. Identification of glucuronide conjugates of ketobemidone and its phase I metabolites in human urine utilizing accurate mass and tandem time-of-flight mass spectrometry.
Sundström I; Hedeland M; Bondesson U; Andrén PE
J Mass Spectrom; 2002 Apr; 37(4):414-20. PubMed ID: 11948848
[TBL] [Abstract][Full Text] [Related]
9. Identification of phase I and phase II metabolites of ketobemidone in patient urine using liquid chromatography-electrospray tandem mass spectrometry.
Sundström I; Bondesson U; Hedeland M
J Chromatogr B Biomed Sci Appl; 2001 Nov; 763(1-2):121-31. PubMed ID: 11710570
[TBL] [Abstract][Full Text] [Related]
10. Method development for identification of ketobemidone metabolites in microdialysate samples by coupled-column capillary liquid chromatography-tandem mass spectrometry.
Sundström I; Andrén PE; Westerlund D
J Chromatogr A; 2008 May; 1189(1-2):503-13. PubMed ID: 18343391
[TBL] [Abstract][Full Text] [Related]
11. Some spiro analogues of the potent analgesic ketobemidone.
Rogers ME; Wilkinson DS; Thweatt JR; Halenda SP
J Med Chem; 1980 Jun; 23(6):688-90. PubMed ID: 6248644
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of ketobemidone in critically ill patients.
Al-Shurbaji A; Tokics L
Br J Clin Pharmacol; 2002 Dec; 54(6):583-6. PubMed ID: 12492604
[TBL] [Abstract][Full Text] [Related]
13. Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone.
Tamsen A; Bondesson U; Dahlström B; Hartvig P
Clin Pharmacokinet; 1982; 7(3):252-65. PubMed ID: 7094500
[TBL] [Abstract][Full Text] [Related]
14. Excretion of ketobemidone in human breast milk.
Gerdin E; Bondesson U; Hartvig P
J Perinat Med; 1996; 24(3):293-5. PubMed ID: 8827580
[TBL] [Abstract][Full Text] [Related]
15. Mass fragmentographic method for the determination of ketobemidone in plasma.
Bondesson U; Hartvig P
J Chromatogr; 1979 Nov; 179(1):207-12. PubMed ID: 536454
[No Abstract] [Full Text] [Related]
16. Comparison of the analgesic efficacy of ketobemidone and morphine for management of postoperative pain in children: a randomized, controlled study.
Jylli L; Lundeberg S; Langius-Eklöf A; Olsson GL
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1256-9. PubMed ID: 15504185
[TBL] [Abstract][Full Text] [Related]
17. [Bioavailability and analgetic effect of sustained-release ketobemidone capsules in patients with chronic pain of cancer].
Kjaer M; Nielsen H; Andersen LS
Ugeskr Laeger; 1993 Mar; 155(11):783-8. PubMed ID: 8096349
[No Abstract] [Full Text] [Related]
18. Enantiomeric conformers of the opioid agonist ketobemidone HCl in the crystal state.
Froimowitz M; Cody V
Chirality; 1993; 5(7):560-4. PubMed ID: 7902122
[TBL] [Abstract][Full Text] [Related]
19. The opioid receptor binding profiles of ketobemidone and morphine.
Christensen CB
Pharmacol Toxicol; 1993 Dec; 73(6):344-5. PubMed ID: 8153059
[No Abstract] [Full Text] [Related]
20. Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1.
Zhang J; Burnell JC; Dumaual N; Bosron WF
J Pharmacol Exp Ther; 1999 Jul; 290(1):314-8. PubMed ID: 10381793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
